Loading…
The role of theophylline in contrast‐induced nephropathy: a case‐control study
Background. Various strategies for the prevention of contrast‐induced nephropathy (CN) have been studied, with conflicting results. Adenosine may play an important role in the pathogenesis of CN. This study prospectively assessed the role of oral theophylline in the prevention of CN. Methods. We ran...
Saved in:
Published in: | Nephrology, dialysis, transplantation dialysis, transplantation, 2002-11, Vol.17 (11), p.1936-1941 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c369t-6cf511bd1445903e2331b949ea12070c6e6fbc2ff3c410bc72e3cbd32a428d0f3 |
---|---|
cites | |
container_end_page | 1941 |
container_issue | 11 |
container_start_page | 1936 |
container_title | Nephrology, dialysis, transplantation |
container_volume | 17 |
creator | Kapoor, Aditya Kumar, Sudeep Gulati, Sanjeev Gambhir, Sanjay Sethi, Ravindra S. Sinha, Nakul |
description | Background. Various strategies for the prevention of contrast‐induced nephropathy (CN) have been studied, with conflicting results. Adenosine may play an important role in the pathogenesis of CN. This study prospectively assessed the role of oral theophylline in the prevention of CN. Methods. We randomized into two groups 70 patients with diabetes mellitus who were undergoing coronary angiography (CAG) with high‐osmolar contrast media. Group I (n=35) underwent routine CAG, and group II (n=35) received oral theophylline 200 mg b.d. 24 h before and for 48 h after CAG. Serum Na+, K+, blood urea nitrogen (BUN), creatinine, osmolality, glomerular filtration rate (GFR) and urinalysis were performed before and after CAG. The 99mTc‐DTPA‐clearance method was used to assess GFR. Results. Following angiography, patients in the control group showed a significant rise in serum creatinine (1.19±0.23 vs 1.44±0.32 mg/dl, P=0.003) and BUN (13.95±2.61 vs 17.55±3.9 mg/dl, P=0.01) along with a fall in GFR (85.4±14.7 vs 66.85±14.8 ml/min, P=0.008). The mean percentage fall in GFR was 35.8%. There was no significant change in serum creatinine (1.16±0.18 vs 1.24±0.21 mg/dl), BUN (12.8±3.36 vs 14.8±2.5 mg/dl) and GFR (86.8±15.8 vs 80.3±16.0 ml/min) in those receiving theophylline. No patient in the theophylline group had a >25% rise in serum creatinine, compared with 7/35 in the control group (P=0.017). In the control group, 11/35 (31%) developed CN, as demonstrated by a ⩾25% fall in GFR, while only one patient in the theophylline group had a fall in GFR (P=0.004). None of the pre‐angiographic variables could predict the development of CN. Conclusions. Following the use of high‐osmolar contrast media for routine CAG, CN may develop in 31% of diabetic patients. Patients who received prophylactic oral theophylline had a significantly lower risk of CN than those who did not. |
doi_str_mv | 10.1093/ndt/17.11.1936 |
format | article |
fullrecord | <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ndt_17_11_1936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_HXZ_CVZ72S80_G</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-6cf511bd1445903e2331b949ea12070c6e6fbc2ff3c410bc72e3cbd32a428d0f3</originalsourceid><addsrcrecordid>eNpFkMFKw0AURQdRbK1uXcr8QNL3ZpJM4k6KtkJB0CrSzTCZTEg0TcJMCmbnJ_iNfompLbq6i3vuXRxCLhF8hIRP66ybovARfUx4dETGGETgMR6Hx2Q8AOhBCMmInDn3BgAJE-KUjJAFgHEIY_K4Kgy1TWVok9OuME1b9FVV1oaWNdVN3Vnluu_Pr7LOttpktDZtYZtWdUV_TRXVypmh_QWbirpum_Xn5CRXlTMXh5yQ57vb1WzhLR_m97Obpad5lHRepPMQMc0wCMIEuGGcY5oEiVHIQICOTJSnmuU51wFCqgUzXKcZZypgcQY5nxB__6tt45w1uWxtuVG2lwhyJ0cOciQKiSh3cobB1X7QbtONyf7xg40B8PZA6Trz8dcr-y4jwUUoF69rOXtZC_YUg5zzH_wEcjk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The role of theophylline in contrast‐induced nephropathy: a case‐control study</title><source>Oxford Journals Online</source><creator>Kapoor, Aditya ; Kumar, Sudeep ; Gulati, Sanjeev ; Gambhir, Sanjay ; Sethi, Ravindra S. ; Sinha, Nakul</creator><creatorcontrib>Kapoor, Aditya ; Kumar, Sudeep ; Gulati, Sanjeev ; Gambhir, Sanjay ; Sethi, Ravindra S. ; Sinha, Nakul</creatorcontrib><description>Background. Various strategies for the prevention of contrast‐induced nephropathy (CN) have been studied, with conflicting results. Adenosine may play an important role in the pathogenesis of CN. This study prospectively assessed the role of oral theophylline in the prevention of CN. Methods. We randomized into two groups 70 patients with diabetes mellitus who were undergoing coronary angiography (CAG) with high‐osmolar contrast media. Group I (n=35) underwent routine CAG, and group II (n=35) received oral theophylline 200 mg b.d. 24 h before and for 48 h after CAG. Serum Na+, K+, blood urea nitrogen (BUN), creatinine, osmolality, glomerular filtration rate (GFR) and urinalysis were performed before and after CAG. The 99mTc‐DTPA‐clearance method was used to assess GFR. Results. Following angiography, patients in the control group showed a significant rise in serum creatinine (1.19±0.23 vs 1.44±0.32 mg/dl, P=0.003) and BUN (13.95±2.61 vs 17.55±3.9 mg/dl, P=0.01) along with a fall in GFR (85.4±14.7 vs 66.85±14.8 ml/min, P=0.008). The mean percentage fall in GFR was 35.8%. There was no significant change in serum creatinine (1.16±0.18 vs 1.24±0.21 mg/dl), BUN (12.8±3.36 vs 14.8±2.5 mg/dl) and GFR (86.8±15.8 vs 80.3±16.0 ml/min) in those receiving theophylline. No patient in the theophylline group had a >25% rise in serum creatinine, compared with 7/35 in the control group (P=0.017). In the control group, 11/35 (31%) developed CN, as demonstrated by a ⩾25% fall in GFR, while only one patient in the theophylline group had a fall in GFR (P=0.004). None of the pre‐angiographic variables could predict the development of CN. Conclusions. Following the use of high‐osmolar contrast media for routine CAG, CN may develop in 31% of diabetic patients. Patients who received prophylactic oral theophylline had a significantly lower risk of CN than those who did not.</description><identifier>ISSN: 0931-0509</identifier><identifier>ISSN: 1460-2385</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/17.11.1936</identifier><identifier>PMID: 12401850</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>acute renal failure ; Administration, Oral ; Adult ; Aged ; angiography ; Blood Urea Nitrogen ; cardiac catheterization ; Case-Control Studies ; Contrast Media - adverse effects ; Coronary Angiography ; Creatinine - blood ; Diabetes Mellitus - diagnostic imaging ; Diatrizoate Meglumine - adverse effects ; Glomerular Filtration Rate - drug effects ; Humans ; Incidence ; Kidney Diseases - chemically induced ; Kidney Diseases - epidemiology ; Kidney Diseases - prevention & control ; Middle Aged ; radiocontrast‐induced nephropathy ; renal haemodynamics ; theophylline ; Theophylline - administration & dosage</subject><ispartof>Nephrology, dialysis, transplantation, 2002-11, Vol.17 (11), p.1936-1941</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-6cf511bd1445903e2331b949ea12070c6e6fbc2ff3c410bc72e3cbd32a428d0f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27900,27901</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12401850$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kapoor, Aditya</creatorcontrib><creatorcontrib>Kumar, Sudeep</creatorcontrib><creatorcontrib>Gulati, Sanjeev</creatorcontrib><creatorcontrib>Gambhir, Sanjay</creatorcontrib><creatorcontrib>Sethi, Ravindra S.</creatorcontrib><creatorcontrib>Sinha, Nakul</creatorcontrib><title>The role of theophylline in contrast‐induced nephropathy: a case‐control study</title><title>Nephrology, dialysis, transplantation</title><addtitle>Nephrol. Dial. Transplant</addtitle><description>Background. Various strategies for the prevention of contrast‐induced nephropathy (CN) have been studied, with conflicting results. Adenosine may play an important role in the pathogenesis of CN. This study prospectively assessed the role of oral theophylline in the prevention of CN. Methods. We randomized into two groups 70 patients with diabetes mellitus who were undergoing coronary angiography (CAG) with high‐osmolar contrast media. Group I (n=35) underwent routine CAG, and group II (n=35) received oral theophylline 200 mg b.d. 24 h before and for 48 h after CAG. Serum Na+, K+, blood urea nitrogen (BUN), creatinine, osmolality, glomerular filtration rate (GFR) and urinalysis were performed before and after CAG. The 99mTc‐DTPA‐clearance method was used to assess GFR. Results. Following angiography, patients in the control group showed a significant rise in serum creatinine (1.19±0.23 vs 1.44±0.32 mg/dl, P=0.003) and BUN (13.95±2.61 vs 17.55±3.9 mg/dl, P=0.01) along with a fall in GFR (85.4±14.7 vs 66.85±14.8 ml/min, P=0.008). The mean percentage fall in GFR was 35.8%. There was no significant change in serum creatinine (1.16±0.18 vs 1.24±0.21 mg/dl), BUN (12.8±3.36 vs 14.8±2.5 mg/dl) and GFR (86.8±15.8 vs 80.3±16.0 ml/min) in those receiving theophylline. No patient in the theophylline group had a >25% rise in serum creatinine, compared with 7/35 in the control group (P=0.017). In the control group, 11/35 (31%) developed CN, as demonstrated by a ⩾25% fall in GFR, while only one patient in the theophylline group had a fall in GFR (P=0.004). None of the pre‐angiographic variables could predict the development of CN. Conclusions. Following the use of high‐osmolar contrast media for routine CAG, CN may develop in 31% of diabetic patients. Patients who received prophylactic oral theophylline had a significantly lower risk of CN than those who did not.</description><subject>acute renal failure</subject><subject>Administration, Oral</subject><subject>Adult</subject><subject>Aged</subject><subject>angiography</subject><subject>Blood Urea Nitrogen</subject><subject>cardiac catheterization</subject><subject>Case-Control Studies</subject><subject>Contrast Media - adverse effects</subject><subject>Coronary Angiography</subject><subject>Creatinine - blood</subject><subject>Diabetes Mellitus - diagnostic imaging</subject><subject>Diatrizoate Meglumine - adverse effects</subject><subject>Glomerular Filtration Rate - drug effects</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kidney Diseases - chemically induced</subject><subject>Kidney Diseases - epidemiology</subject><subject>Kidney Diseases - prevention & control</subject><subject>Middle Aged</subject><subject>radiocontrast‐induced nephropathy</subject><subject>renal haemodynamics</subject><subject>theophylline</subject><subject>Theophylline - administration & dosage</subject><issn>0931-0509</issn><issn>1460-2385</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpFkMFKw0AURQdRbK1uXcr8QNL3ZpJM4k6KtkJB0CrSzTCZTEg0TcJMCmbnJ_iNfompLbq6i3vuXRxCLhF8hIRP66ybovARfUx4dETGGETgMR6Hx2Q8AOhBCMmInDn3BgAJE-KUjJAFgHEIY_K4Kgy1TWVok9OuME1b9FVV1oaWNdVN3Vnluu_Pr7LOttpktDZtYZtWdUV_TRXVypmh_QWbirpum_Xn5CRXlTMXh5yQ57vb1WzhLR_m97Obpad5lHRepPMQMc0wCMIEuGGcY5oEiVHIQICOTJSnmuU51wFCqgUzXKcZZypgcQY5nxB__6tt45w1uWxtuVG2lwhyJ0cOciQKiSh3cobB1X7QbtONyf7xg40B8PZA6Trz8dcr-y4jwUUoF69rOXtZC_YUg5zzH_wEcjk</recordid><startdate>200211</startdate><enddate>200211</enddate><creator>Kapoor, Aditya</creator><creator>Kumar, Sudeep</creator><creator>Gulati, Sanjeev</creator><creator>Gambhir, Sanjay</creator><creator>Sethi, Ravindra S.</creator><creator>Sinha, Nakul</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200211</creationdate><title>The role of theophylline in contrast‐induced nephropathy: a case‐control study</title><author>Kapoor, Aditya ; Kumar, Sudeep ; Gulati, Sanjeev ; Gambhir, Sanjay ; Sethi, Ravindra S. ; Sinha, Nakul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-6cf511bd1445903e2331b949ea12070c6e6fbc2ff3c410bc72e3cbd32a428d0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>acute renal failure</topic><topic>Administration, Oral</topic><topic>Adult</topic><topic>Aged</topic><topic>angiography</topic><topic>Blood Urea Nitrogen</topic><topic>cardiac catheterization</topic><topic>Case-Control Studies</topic><topic>Contrast Media - adverse effects</topic><topic>Coronary Angiography</topic><topic>Creatinine - blood</topic><topic>Diabetes Mellitus - diagnostic imaging</topic><topic>Diatrizoate Meglumine - adverse effects</topic><topic>Glomerular Filtration Rate - drug effects</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kidney Diseases - chemically induced</topic><topic>Kidney Diseases - epidemiology</topic><topic>Kidney Diseases - prevention & control</topic><topic>Middle Aged</topic><topic>radiocontrast‐induced nephropathy</topic><topic>renal haemodynamics</topic><topic>theophylline</topic><topic>Theophylline - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kapoor, Aditya</creatorcontrib><creatorcontrib>Kumar, Sudeep</creatorcontrib><creatorcontrib>Gulati, Sanjeev</creatorcontrib><creatorcontrib>Gambhir, Sanjay</creatorcontrib><creatorcontrib>Sethi, Ravindra S.</creatorcontrib><creatorcontrib>Sinha, Nakul</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kapoor, Aditya</au><au>Kumar, Sudeep</au><au>Gulati, Sanjeev</au><au>Gambhir, Sanjay</au><au>Sethi, Ravindra S.</au><au>Sinha, Nakul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of theophylline in contrast‐induced nephropathy: a case‐control study</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><addtitle>Nephrol. Dial. Transplant</addtitle><date>2002-11</date><risdate>2002</risdate><volume>17</volume><issue>11</issue><spage>1936</spage><epage>1941</epage><pages>1936-1941</pages><issn>0931-0509</issn><issn>1460-2385</issn><eissn>1460-2385</eissn><abstract>Background. Various strategies for the prevention of contrast‐induced nephropathy (CN) have been studied, with conflicting results. Adenosine may play an important role in the pathogenesis of CN. This study prospectively assessed the role of oral theophylline in the prevention of CN. Methods. We randomized into two groups 70 patients with diabetes mellitus who were undergoing coronary angiography (CAG) with high‐osmolar contrast media. Group I (n=35) underwent routine CAG, and group II (n=35) received oral theophylline 200 mg b.d. 24 h before and for 48 h after CAG. Serum Na+, K+, blood urea nitrogen (BUN), creatinine, osmolality, glomerular filtration rate (GFR) and urinalysis were performed before and after CAG. The 99mTc‐DTPA‐clearance method was used to assess GFR. Results. Following angiography, patients in the control group showed a significant rise in serum creatinine (1.19±0.23 vs 1.44±0.32 mg/dl, P=0.003) and BUN (13.95±2.61 vs 17.55±3.9 mg/dl, P=0.01) along with a fall in GFR (85.4±14.7 vs 66.85±14.8 ml/min, P=0.008). The mean percentage fall in GFR was 35.8%. There was no significant change in serum creatinine (1.16±0.18 vs 1.24±0.21 mg/dl), BUN (12.8±3.36 vs 14.8±2.5 mg/dl) and GFR (86.8±15.8 vs 80.3±16.0 ml/min) in those receiving theophylline. No patient in the theophylline group had a >25% rise in serum creatinine, compared with 7/35 in the control group (P=0.017). In the control group, 11/35 (31%) developed CN, as demonstrated by a ⩾25% fall in GFR, while only one patient in the theophylline group had a fall in GFR (P=0.004). None of the pre‐angiographic variables could predict the development of CN. Conclusions. Following the use of high‐osmolar contrast media for routine CAG, CN may develop in 31% of diabetic patients. Patients who received prophylactic oral theophylline had a significantly lower risk of CN than those who did not.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>12401850</pmid><doi>10.1093/ndt/17.11.1936</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0931-0509 |
ispartof | Nephrology, dialysis, transplantation, 2002-11, Vol.17 (11), p.1936-1941 |
issn | 0931-0509 1460-2385 1460-2385 |
language | eng |
recordid | cdi_crossref_primary_10_1093_ndt_17_11_1936 |
source | Oxford Journals Online |
subjects | acute renal failure Administration, Oral Adult Aged angiography Blood Urea Nitrogen cardiac catheterization Case-Control Studies Contrast Media - adverse effects Coronary Angiography Creatinine - blood Diabetes Mellitus - diagnostic imaging Diatrizoate Meglumine - adverse effects Glomerular Filtration Rate - drug effects Humans Incidence Kidney Diseases - chemically induced Kidney Diseases - epidemiology Kidney Diseases - prevention & control Middle Aged radiocontrast‐induced nephropathy renal haemodynamics theophylline Theophylline - administration & dosage |
title | The role of theophylline in contrast‐induced nephropathy: a case‐control study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T12%3A34%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20theophylline%20in%20contrast%E2%80%90induced%20nephropathy:%20a%20case%E2%80%90control%20study&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=Kapoor,%20Aditya&rft.date=2002-11&rft.volume=17&rft.issue=11&rft.spage=1936&rft.epage=1941&rft.pages=1936-1941&rft.issn=0931-0509&rft.eissn=1460-2385&rft_id=info:doi/10.1093/ndt/17.11.1936&rft_dat=%3Cistex_cross%3Eark_67375_HXZ_CVZ72S80_G%3C/istex_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c369t-6cf511bd1445903e2331b949ea12070c6e6fbc2ff3c410bc72e3cbd32a428d0f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/12401850&rfr_iscdi=true |